What is Allara?
Allara operates as a digital health platform dedicated to improving access to expert care for women facing chronic hormonal and gynecologic conditions. By connecting patients with specialized medical practitioners and Registered Dietitians, the platform offers comprehensive support encompassing medical treatment, lifestyle adjustments, and emotional well-being. This approach aims to enhance health outcomes and help individuals achieve their personal health objectives, particularly for conditions such as polycystic ovary syndrome (PCOS) and endometriosis.
How much funding has Allara raised?
Allara has raised a total of $36M across 2 funding rounds:
Series A
$10M
Series B
$26M
Series A (2023): $10M with participation from Google Ventures
Series B (2025): $26M led by Index Ventures and GV
Key Investors in Allara
Index Ventures
Index Ventures is a venture capital firm that invests in entrepreneurs from seed to IPO, focusing on bold ideas that challenge the status quo. They partner with founders globally to build enduring companies.
GV
GV is a venture capital firm that invests across multiple stages and sectors, with a focus on enterprise solutions, life sciences, consumer products, and frontier technology. They provide financial backing to promising startups and growth-stage businesses worldwide.
Google Ventures
Undisclosed investor participating in the funding round.
What's next for Allara?
The recent major strategic investment signals a pivotal phase for Allara, likely enabling the company to scale its operations, expand its service offerings, and deepen its market penetration. This capital infusion is expected to fuel further innovation in its specialty care model, potentially leading to broader accessibility for women requiring expert management of hormonal and gynecologic health. The company's focus on chronic condition support positions it for sustained growth within the digital health sector.
See full Allara company page
